MedPath

Jiangsu Province Hospital (The First Affiliated Hospital With Nanjing Medical University)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Intravenous Dexmedetomidine for Cesarean Section

Phase 4
Completed
Conditions
Breast Feeding
Analgesia Obstetrical
Postoperative Pain
Interventions
First Posted Date
2017-02-28
Last Posted Date
2020-01-13
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
120
Registration Number
NCT03065530
Locations
🇨🇳

The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China

TCM Clinical Practice Rehabilitation of Post-stroke Spasticity

Not Applicable
Conditions
Stroke
First Posted Date
2017-02-16
Last Posted Date
2017-02-16
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
1208
Registration Number
NCT03054974
Locations
🇨🇳

Jiangsu Province Hospital, Nanjing, Jiangsu, China

The Comparison Between the PVAM and CPVI for the Patients of PAF

Not Applicable
Completed
Conditions
Atrial Fibrillation
Pulmonary Vein Isolation
First Posted Date
2017-01-20
Last Posted Date
2018-07-20
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
180
Registration Number
NCT03026413

Therapeutic Effect of Local Hypothermia in Treatment of Acute Myocardial Infarction

Not Applicable
Conditions
Acute Myocardial Infarction
First Posted Date
2017-01-09
Last Posted Date
2017-01-09
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
300
Registration Number
NCT03015155

Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis

Phase 3
Conditions
Colon Cancer
Interventions
Drug: Peri-operative chemotherapy
Drug: postoperative chemotherapy
First Posted Date
2016-09-23
Last Posted Date
2016-09-23
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
240
Registration Number
NCT02912052
Locations
🇨🇳

Jiangsu province hospital, Nanjing, Jiangsu, China

Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid

Conditions
Pleural Diseases
Malignancy
Ascites
Pleural Effusion
First Posted Date
2016-09-07
Last Posted Date
2020-02-06
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
1000
Registration Number
NCT02891642
Locations
🇨🇳

The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

🇨🇳

The First Affiliated Hospital with Nanjing Medical University, Nanjin, Jiangsu, China

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

Phase 2
Conditions
Colon Cancer
Interventions
Drug: Postoperative chemotherapy
Drug: Neoadjuvant chemotherapy
First Posted Date
2016-08-29
Last Posted Date
2016-08-30
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
400
Registration Number
NCT02882269

Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma

Phase 2
Conditions
Relapse/Refratory Peripheral T Cell Lymphoma
Interventions
Drug: C-CPT
First Posted Date
2016-08-25
Last Posted Date
2019-01-08
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
45
Registration Number
NCT02879526
Locations
🇨🇳

HuaiAn First People's Hospital, HuaiAn, Jiangsu, China

🇨🇳

WuXi People's Hospital, WuXi, Jiangsu, China

Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation

Early Phase 1
Conditions
Age Related Macular Degeneration
Macular Degeneration
AMD
Interventions
Drug: fRPE cells
First Posted Date
2016-08-16
Last Posted Date
2017-06-16
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
6
Registration Number
NCT02868424
Locations
🇨🇳

The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China

Ad-HGF Treatment for Myocardial Infarction

Phase 1
Conditions
Myocardial Infarction
Interventions
Other: 0.9% NaCl
First Posted Date
2016-07-26
Last Posted Date
2016-07-26
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Target Recruit Count
100
Registration Number
NCT02844283
© Copyright 2025. All Rights Reserved by MedPath